Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2020-06-05 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
经世律师事务所关于金宇生物技术股份有限公司差异化分红事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding a differentiated dividend distribution related to the company's share repurchase program. It discusses the legal basis, the dividend plan, calculation methods, and concludes on the compliance of the dividend distribution with relevant laws and regulations. The document is not a financial report, earnings release, or management discussion. It is a legal opinion specifically about dividend distribution and share repurchase compliance. It does not announce voting results, changes in management, or capital changes directly, but rather provides a legal opinion on a dividend matter. Given the nature and content, this fits best under Regulatory Filings (RNS), as it is a compliance/legal opinion document that does not fit other specific categories.
2020-06-05 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about its use of idle funds for cash management through various entrusted financial products. It includes specifics about the entrusted parties, contract terms, risk control measures, financial data, and board approval. The document is not a full financial report like an annual or interim report, nor is it a transcript, audit report, or legal proceeding. It is a regulatory announcement about capital management activities, specifically about the company's financing and investment activities with its own funds. This fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a simple report publication notice. Therefore, the classification is CAP with high confidence.
2020-06-01 Chinese
关于股东股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a formal announcement regarding the release of pledged shares by a major shareholder of the company. It details the number of shares released from pledge, the remaining pledged shares, and the shareholder's total holdings. There is no financial performance data, no discussion of management or board changes, no earnings or quarterly report content, and no mention of legal proceedings or mergers. The document is a specific disclosure about share pledge status, which fits the category of Major Shareholding Notification (MRQ) as it involves changes in significant share ownership levels and pledge status. The document length is short and focused solely on this shareholding update, confirming it is not a full report or other type of filing.
2020-05-21 Chinese
关于股份回购实施结果暨股份变动公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding the implementation results of a share repurchase program by the company. It includes specifics about the number of shares repurchased, prices, total funds used, approvals, and subsequent shareholding changes. The text explicitly discusses the repurchase of shares, the use of funds, and the impact on share capital, which aligns with a report on the company's own share transactions. It is not a general financial report, earnings release, or regulatory filing. The document length is 2831 characters, which is relatively short but contains substantive details about the share repurchase, not just an announcement of a report. Therefore, it fits best under the category of Transaction in Own Shares (POS).
2020-05-15 Chinese
关于以集中竞价交易方式回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and compliance with regulations. It references previous announcements and reports related to the share buyback but does not contain financial statements or detailed financial analysis. The document is short (818 characters) and serves as an update on the share repurchase activity rather than a full financial report or initial announcement of results. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares.
2020-05-07 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the progress of using idle self-owned funds for cash management through entrusted financial products. It includes specifics about the entrusted financial products, contract terms, risk control measures, details about the entrusted parties, and the company's financial data. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a brief announcement or a certification. It is a regulatory announcement about capital management activities, specifically about financing and investment of idle funds. This fits best under the category of Capital/Financing Update (CAP), as it provides updates on the company's financing activities and capital management strategies. The document length and detail support this classification with high confidence.
2020-04-29 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.